Men carry more of the risk of heart and metabolic disease (cardiometabolic risk). Yet women are receiving medical weight loss treatments at far higher rates than men.
Mosh is proud to share a practical guide to help close that gap, one consult at a time.
of Mosh weight loss patients are women
Mosh internal data 2025
Australia has no national strategy to address the gap between men and women using medical weight loss treatment.
The Mosh Men’s Initiative is calling for one.
$500k for public awareness
Over the next 12 months, Mosh will invest $500k in targeted public health messaging to raise awareness of men’s weight issues.
A public guide for GPs
Mosh is sharing a public guide to help GPs discuss weight with male patients.
An invitation to shape policy
Mosh is inviting government, clinicians and health bodies to discuss how Australia can better reach men with weight and metabolic health care.
Fewer GP visits
Men who saw a GP
Women who saw a GP
Men also average fewer Medicare-subsidised GP consultations each year: 5.2, compared with 7.1 for women.
Delayed weight conversations
Men are less likely to start a weight conversation with a health practitioner. For many, that conversation does not happen until a health crisis, such as a heart attack or a diabetes diagnosis.
“We have seen this playbook before with mental health. Men suffer in silence, and pay for it with their lives.”
Dr Kieran Dang, Chief Medical Officer, Mosh
Every tool we have, for every man who needs it.
Raise it first
Many men are waiting for someone else to start the conversation.
Start with health risks
Focus on heart, liver, kidney, sleep and hormone health.
Make the conversation easier
Telehealth may help reduce the social barriers to starting a weight conversation.
For media enquiries contact
Spokesperson
Dr Kieran Dang, Chief Medical Officer, Mosh and Moshy.
Available for interview on request.
Mosh and Moshy are the largest Australian-owned digital health platforms, helping men and women access personalised healthcare online.
Founded in Bondi in 2016, the brands connect patients with clinically independent Australian healthcare practitioners and pharmacy partners.
General information for health professionals; not a substitute for clinical judgement.
Trial results describe study populations and doses. TGA indications and PBS criteria change; check current product information.
Decoder prompts were drafted by Mosh for GP discussion. Erectile dysfunction (ED) as a marker of cardiovascular risk is well established. Hormonal data for medical weight loss treatments is emerging.